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Background: Extended-spectrum β-lactamases (ESBLs), particularly CTX-M- type ESBLs, are among the most
important resistance determinants spreading worldwide in Enterobacteriaceae. The aim of this study was to
characterize a collection of 163 ESBL-producing Escherichia coli collected in Tunisia, their ESBL-encoding plasmids
and plasmid associated addiction systems.
Results: The collection comprised 163 ESBL producers collected from two university hospitals of Sfax between 1989
and 2009. 118 isolates harbored blaCTX-M gene (101 blaCTX-M-15 gene and 17 blaCTX-M-14 gene). 49 isolates carried
blaSHV-12 gene, 9 blaSHV-2a gene and only 3 blaTEM-26 gene. 16 isolates produced both CTX-M and SHV-12. The 101
CTX-M-15-producing isolates were significantly associated to phylogroup B2 and exhibiting a high number of
virulence factors. 24 (23.7%) of the group B2 isolates belonged to clonal complex ST131. Pulsed-field gel
electrophoresis (PFGE) typing revealed a genetic diversity of the isolates. 144 ESBL determinants were transferable
mostly by conjugation. The majority of plasmid carrying blaCTX-M-15 genes (72/88) were assigned to various single
replicon or multireplicon IncF types and had significantly a higher frequency of addiction systems, notably the
VagCD module.
Conclusion: This study demonstrates that the dissemination of CTX-M-15 producing E. coli in our setting was due
to the spread of various IncF-type plasmids harboring multiple addiction systems, into related clones with high
frequency of virulence determinants.
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Extended-spectrum β-lactamases (ESBLs) are among the
most important resistance determinants spreading world-
wide in Enterobacteriaceae [1,2]. During the 1980s, ESBLs
evolved from TEM and SHV broad-spectrum-β-lactamases,
frequently associated to Klebsiella pneumoniae involved in
nosocomial outbreaks. Over the last decade, CTX-M-type
ESBLs have increased dramatically, and become the
most prevalent ESBLs worldwide, frequently associated* Correspondence: basma_mnif@yahoo.fr
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reproduction in any medium, provided the orto Escherichia coli. Among the CTX-M-type ESBLs,
CTX-M-15 is now the most widely distributed in E. coli
which became a major cause of infections in both
community and hospitals [1,2]. A few explanations
have been proposed on what makes CTX-M-15-producing
E. coli isolates so successful. First, it has been proposed that
the strain virulence background could be involved in this
dissemination process. In fact, many reports have
shown that CTX-M-15 is closely associated with the
international and pandemic uropathogenic O25:H4-ST131
clone, which have specific virulence factors [3,4]. Second,
the association of CTX-M-15 with the IncF plasmids,
which are well adapted to E. coli, may facilitate the spreadd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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virulence background and IncF plasmids bearing CTX-
M-15, it was recently suggested that the association of
various plasmid addiction systems may contribute to the
plasmid maintenance in their host [6-8]. An addiction
system or a toxin-antitoxin system helps maintain
plasmids in bacteria during host replication by killing
of plasmid-free cells resulting from segregation or repli-
cation defects [9].
In Tunisia, SHV-2 was the first ESBL to be detected,
in 1984 from a K. pneumoniae clinical isolate [10]. Then,
various other types of ESBLs, SHV-12, SHV-2a, CTX-
M-15, CTX-M-14, CTX-M-9, CTX-M-16, CTX-M-27
and CTX-M-28 have been reported in different Tunisian
hospitals with CTX-M-15 being the most prevalent
[11-15]. This study was designed to characterize the
ESBL-producing E. coli collected in two university hospi-
tals of Sfax, in the southern part of Tunisia and to inves-
tigate their virulence background, their ESBL-encoding
plasmids and their plasmid addiction systems.Methods
E. coli isolates
163 isolates were randomly selected from the collection of
ESBL-producing E. coli isolates maintained at -80°C in the
Microbiology laboratory of Habib Bourguiba hospital.
The 163 isolates were collected from the two univer-
sity hospital of Sfax in Tunisia during the following
years: 1989-1990 (6), 2000 (9), 2001 (18), 2002 (9),
2003 (30), 2004 (26), 2006 (36) and 2009 (29). These
isolates were obtained mainly from urine (124), but
also from blood (20), wound swabs (10), abdominal
fluid (5) and sputum (4).Antibiotic susceptibility testing
The susceptibility to 16 antimicrobial agents (amoxicil-
lin, amoxicillin + clavulanic acid, ticarcillin, ticarcillin +
clavulanic acid, cefalothin, cefoxitin, ceftazidime, cefotaxime,
cefepime, gentamicin, amikacin, nalidixic acid, norfloxacin,
sulfamethoxzole/trimethoprim and tetracycline) was deter-
mined by the disk diffusion method according to the guide-
lines of the CLSI [16]. All isolates were confirmed for ESBL
production using the double disk synergy method.Identification of bla genes
The resistance genes blaTEM, blaSHV and blaCTX-M re-
sponsible for the ESBL activity were identified by PCR-
sequencing [17]. PCR products were sequenced on ABI
Prism 3100 automated sequencer (Applied Biosystems,
Foster City, CA) and were analyzed using NCBI BLAST
program. (http://www.ncbi.nlm.nih.gov/).Strain typing
The phylogenetic group of the ESBL-producing E. coli
was determined by a multiplex PCR assay [18]. Isolates
belonging to phylogenetic group B2 were screened with
a previously established PCR-based method to identify
the O25b subtype [19]. Furthermore, multilocus sequence
typing (MLST) using the scheme of the Institut Pasteur,
Paris, France (www.pasteur.fr/mlst) was used to confirm
that CTX-M-15-producing E. coli O25b belonged to the
international clone ST131 [19]. Genetic relatedness of the
ESBL-producing strains was studied by PFGE following
extraction of genomic DNA and digestion with XbaI
PFGE according to a standard protocol using a GenePath
system (Bio-Rad). PFGE banding profiles were compared
digitally using Fingerprint II software (Bio-Rad) and re-
latedness was calculated using the unweighted pair group
method with arithmetic mean (UPGMA) algorithm with
similarity of bands using the Dice similarity indices.
Isolates were considered to belong to the same PFGE
cluster if their Dice similarity index was >80% [20].
Transfer of ESBL resistance determinants and plasmid
analysis
Transfer of ESBL encoding genes by conjugation was
performed by matting-out assays using E. coli J53-2 RifR or
E. coli HB101 StrR as recipient strains. Transconjugants
were selected on MH agar containing rifampin (250 μg/mL)
or streptomycin (50 μg/mL) plus ceftazidime or cefotaxime
(2 μg/ml). When plasmids were not transferable by conjuga-
tion, a transformation experiment was assayed. Plasmid
DNAobtained using theQIAprep SpinMiniprep kit (Qiagen)
were electroporated into E. coli DH10B (Invitrogen). Trans-
formants were selected on MH agar plates supplemented
with ceftazidime (2 μg/mL) or cefotaxime (2 μg/mL). Plas-
mids were classified according to their incompatibility
group using the PCR replicon-typing scheme described
previously [21].
Detection of virulence factors and plasmid addiction
systems
For the ESBL-producing isolates, 17 virulence-associated
genes were sought as previously described: fimH (type 1
fimbriae), papG (P fimbriae adhesion) alleles I, II and
III, papC, sfa/focDE (S and F1C fimbriae), afa/draBC
(Dr-binding adhesions), iha (adhesion siderophore), hra
(heat(resistant agglutinin), iutA (aerobactin receptor), fyuA
(yersiniabcatin receptor), cnf-1 (cytotoxic necrotizing factor
type 1), hlyA (α-hemolysin), sat (secreted autoreceptor
toxin), kpsMT II (group II capsule), traT (serum resistance-
associated) and pheR (phenylalanine tRNA, site of insertion
from PAI V) [22].
For E. coli recipient strains, seven plasmid addiction
system PemK–PemI (plasmid emergency maintenance),
CcdA–CcdB (coupled cell division locus) RelB–RelE
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(DNA replication), VagC-VagD (virulence-associated pro-
tein), Hok–Sok (host-killing) and PndA–PndC (promotion
of nucleic acid) were sought by PCR as described previ-
ously [7].
Statistical analysis
Comparisons were determined using Pearson’s x2 or
Fisher’s exact test when appropriate, and a P value < 0.05
was considered significant. Statistical analysis was carried
out using SPSS version 11.5 for Windows.
Results
ESBL characterization and antimicrobial resistance
PCR and sequence analysis revealed that 118 of the 163
(72%) ESBL-positive E. coli clinical isolates were CTX-M
producers, 101 producing CTX-M-15 and 17 CTX-
M-14. 49 isolates produced SHV-12, 9 SHV-2a and only
3, TEM-26. 16 isolates were found to carry both blaSHV-12
gene and blaCTX-M gene (10 blaCTX-M-15 and 6 blaCTX-M-
14 genes). The occurrence of blaSHV genes decreased over
time, whereas blaCTX-M genes became predominant since
2003 (Figure 1). The ESBL-producing E. coli isolates were
highly resistant to the aminoglycosides, gentamicin (78%),
amikacin (32%), to fluoroquinolones (ciprofloxacin, 62%)
and to trimethoprim-sulfamethoxazole (65%).
Transfer of resistance and plasmid replicon type
determination
144 over 179 (80%) ESBL determinants were transferable
by conjugation (n = 136) or transformation (n = 8); these
encoded CTX-M-15 (n = 88), CTX-M-14 (n = 15), SHV-
12 (n = 30), SHV-2a (n = 9) and TEM-26 (n = 2) (Table 1).
Only the blaCTX-M gene was detected in recipient strains
corresponding to E. coli isolates harboring both blaSHV-12
gene and blaCTX-M gene, except for one isolate in which
the blaSHV-12 determinant was transferred. 35 ESBL deter-
minants, were non transferable despite repeated conjuga-
















Figure 1 Evolution of SHV and CTX-M ESBL type incidence
during the study period.Fifteen of the 144 ESBL-carrying plasmids (10.4%) were
non-typeable for the incompatibility groups sought by the
PCR-based replicon typing; 9 of these encoded the CTX-
M-14 ESBL, 4 encoded SHV-12 and 2 encoded CTX-
M-15. Eighty-five of the 144 ESBL-carrying plasmids
(59%) belonged to IncF replicon types. IncF replicons were
associated with both SHV and CTX-M ESBL types but
were significantly more prevalent in CTX-M-carrying
plasmids (CTX-M ESBL type versus SHV, p < 0.001), espe-
cially CTX-M-15 ones (Table 1). In fact, 82% of CTX-
M-15 genes (72/88) were carried on IncF replicons, 49 on
a single FII rep type and, 24 on multiple IncF replicons,
occurring in 4 different combinations of IncFII, IncFIA,
and/or IncFIB replicons, but FII-FIA-FIB (n = 15) being
most frequent (Table 1). HI2 and A/C replicons were as-
sociated with SHV ESBL types and L/M and I1 replicons
with CTX-M ESBL types (Table 1).
Strain typing
The 163 ESBL-producing E. coli isolates divided among all
four major phylogenetic groups: B2 (n = 61), A (n = 54), D
(n = 24) and B1 (n = 24). Group B2 was significantly more
common among CTX-M-15 producers and group A
among SHV producers (Table 2). RfbO25 PCR and MLST
revealed that 39% of the group B2 isolates (24/61) and
46.1% of the CTX-M-15-producing B2 isolates (24/52)
belonged to the internationally disseminated uropathogenic
clone O25:H4-ST131. Of note, these ST131 isolates were
recovered mainly in 2003 and 2004 (21 ST131 isolates
which accounted for 75% of the B2 isolates) and more
rarely in 2006 (2 ST131 isolates) and 2009 (1 ST131 iso-
late). All of the 163 E. coli isolates were subjected to PFGE
analysis. However, 15 isolates could not be typed by PFGE.
Examination of the 148 PFGE patterns revealed a great
genomic diversity with 93 different pulsotypes (62.8%) (Data
not shown). 68 isolates corresponded to non-genetic-related
isolates, whereas 90 isolates were assigned to 25 minor
clonal groups with >80% of similarity; two clusters of 8
isolates, 4 clusters of 4 or 5 isolates and the 19 remaining
clusters comprised three or two isolates. The closely re-
lated E. coli strains were isolated from different wards and
years indicating both cross transmission and persistence
of some clones in our settings. The SHV-producing
isolates were often clonally related, whilst the CTX-M
producers were more genetically diverse. Of note, the 22
ST131 strains constituted one large cluster defined at the
61% similarity level; witch was closely tied to a representa-
tive strain of the ST131 clonal complex (TN03, [21]). The
ST131 cluster, in turn, comprised 6 separate PFGE groups,
as defined at the 80% similarity level (Figure 2).
Virulence genotyping
The results of the distribution of virulence determinants in
E. coli isolates in relation with ESBL type and phylogenetic
Table 1 Number of replicons according to ESBL type identified in the E. coli-recipient strains
ESBL type N Replicon type
All F * F multireplicon type HI2* I1 L/M A/C N ND
FII* FIA-FIB FII-FIA FII-FIA-FIB FII-FIB
All 144 85 49 5 9 18 4 16 5 14 5 4 15
TEM 2 0 0 0 0 0 0 0 0 2 0 0 0
TEM-26 2 2
SHV 39 12 0 3 5 3 1 14 0 2 5 2 4
SHV-2a 9 1 1 2 1 4 1
SHV-12 30 9 3 5 3 12 1 1 1 4
CTX-M 103 73* 49 2 4 15 3 2 5 10 0 2 11
CTX-M-14 15 1 1 0 0 0 0 0 2 3 0 0 9
CTX-M-15 88 72† 48 2 4 15 3 2 3 7† 0 2 2
ND not determined.
*: p < 0.05 for CTX-M ESBLs vs. non CTX-M ESBLs.
†: p < 0.05 for CTX-M-15 ESBL vs. other ESBLs.
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genes sought were identified in at least 3 isolates. The most
prevalent virulence genes were fimH (84.7%), followed by
traT (73%), fyuA (63.8%), pheR (60.1%), and iutA (50.3%).
Isolates belonging to the virulent phylogenetic groups B2
and D had averages of 8.6 and 5.2 virulence factor genes
each, respectively, compared with 3 and 3.9, respectively,
for isolates belonging to groups A and B1. ESBL-producing
E. coli isolates belonging to group B2 were significantly
more positive for the adhesins iha, sfa/foc and papG II and
the toxins sat, hylA and cnf1 (p < 0.001). Accordingly, dis-
tribution rates of most virulence determinants were higher
in CTX-M producing E. coli isolates than in non-CTX-M
producers, as the CTX-M producers especially CTX-M-15
ones were significantly associated to phylogenetic group
B2. However, the differences were not significant, except
for papG allele II, iha, iutA, sat, hylA, traT, and kpsM II
(Table 3). In fact the B2 isolates with CTX-M-15 had the
highest mean score of 8.9 virulence factor genes (Table 3).
Of note, the ST131 isolates didn’t exhibit the same viru-
lence profiles. Only five different virulence genes were
uniformly present in all 24 ST131 isolates, including fimH,
iha, sat, fyuA, iutA genes and only 16 ST131 isolates
belonged to 3 unique virulence profiles. The virulenceTable 2 Phylogenetic groups of ESBL-producing E. coli
isolates






Total number 163 (%) 118 45 101
A 54 (33.1) 34 20 26
B1 24 (14.7) 12 12 10
B2 61 (37.4) 55 † 6 52 √
D 24 (14.7) 17 7 13
†: p < 0.0005 for CTX-M B2 producers vs no CTX-M B2 producers.
√: p < 0.0005 for CTX-M-15 B2 producers vs no CTX-M-15 B2 producers.profiles corresponded inconsistently with PFGE type,
suggesting ongoing evolution of virulence genotypes.
Moreover, these ST131 isolates were carrying 16 CTX-
M-15-plasmids of different types including 7 FIA-FIB-FII,
3 FIA-FII, 3 FII, 2 I1 and one untypeable replicon.
Addiction systems of ESBL-carrying plasmids
In total, 187 plasmid addiction systems were detected in
plasmids encoding ESBLs (mean 1.29, range = 0-4 per
recipient strain). pemKI, hok-sok, ccdAB and vagCD were
the most frequently represented systems (Table 4). None
of the plasmids harbored parDE or relBE and only 5
IncI1 plasmids carried the pndAC system. The plasmids
bearing CTX-M-15 had more addiction systems than
those bearing other ESBLs (mean of 1.62 vs 0.73, re-
spectively, P < 0.001). pemKI, vagCD and hok-sok were
significantly more prevalent in CTX-M-15-carrying plas-
mids (Table 4). In addition, the mean number of addic-
tion systems was higher in CTX-M-15-carrying plasmids
than in CTX-M-14 carrying ones. Indeed, when the type
of replicon was considered, the frequency of addiction
systems was the highest in IncF plasmids, which were
significantly associated to CTX-M-15-carrying plasmids,
and IncI1 ones (mean: 1.90 IncF plasmids and 1.8 IncI1
vs 0.31 other plasmids, P < 0.001). IncA/C, IncN, IncHI2
were mostly devoid of addiction systems (Table 2).
pemKI, hok-sok, ccdAB and vagCD systems were signifi-
cantly more abundant in IncF plasmids, especially those
carrying CTX-M-15 ESBLs (Table 4). When the type of
IncF replicons was considered, we remarked that there
were no clear relationships between the numbers of the
combination of the addiction systems and the different
IncF replicon combinations. Nevertheless, the IncFII
replicon alone was of the lowest frequency of addiction
systems and lacked the ccdAB and vagCD systems. The
FIA-FIB-FII replicon type showed the highest frequency
Strain CTX-M year
code          type  
Figure 2 XbaI-PFGE dendrogram for 22 CXT-M-15-positive E. coli isolates from ST131 and a representative ST131 strain from France.
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replicon combinations comprising the FIA replicons
(Table 4). Statistical analysis showed that vagCD is associ-
ated with FIA replicons. Moreover, 10 of the 16 (52.5%)
CTX-M-15 plasmids carried by ST131 isolates were bear-
ing the vagCD systems. In fact, the vagCD system was sig-
nificantly associated to the CTX-M15-producing plasmids
carried by ST131 isolates (P < 0.0001).
Discussion
This study provides molecular-epidemiological data on
ESBL-carrying E. coli isolated in the clinical setting of the
two university hospitals of Sfax in Tunisia, in the end of
the eighties and the 2000s. This study demonstrates a
temporal shift in the prevalence of ESBL types (Figure 1).
Thus the CTX-M-type ESBLs have clearly been predom-
inant during the last decade, as has been described world-
wide [1,2]. The SHV-2 was the first ESBL to be isolated, in
1984 from a Klebsiella pneumoniae isolate in Tunisia [10].
Until the late 1990s, SHV enzymes, especially SHV-12
and SHV-2a, were the most common ESBLs frequently
associated with K. pneumoniae involved in nosocomial
outbreaks in many Tunisian hospitals including our hos-
pital [10,15,23]. In the 2000s, the prevalence of CTX-M
increased steadily especially CTX-M-15 type, whereas that
of SHV decreased dramatically. In fact, all the 29 studied
E. coli isolates in 2009 were producing CTX-M-15
ESBL, 2 of these were co-producing SHV-12 ESBL. Inaccordance with previous reports on distribution of
ESBL in Enterobacteriaceae, performed in Tunisia and
worldwide, we have shown that the CTX-M-15 ESBL
was the most prevalent ESBL in our setting [1,2,12-15].
Recent reports indicate that worldwide dissemination of
CTX-M-15 is mediated by clonally related E. coli
strains, especially a specific clone of phylogroup B2,
ST131 [3,4,24]. Accordingly, in the present study, 24/101
(23.7%) of the CTX-M-15-producing strains belonged to
clone ST131. E. coli ST131 was previously reported in
Tunisia in different hospitals since 2005 [13,14,24,25].
One of the Tunisian studies performed in Sousse from
May 2005 to May 2006 identified clone ST131 in 23/31
(74%) of CTX-M-15-producing E. coli and showed that
these 23 isolates had the same pulsotype and the same
virulence genotype [14]. However, many reports have
demonstrated both homogeneity and considerable diver-
sity in PFGE profiles (<65% similarity) and in virulence
gene profiles reflecting the dual phenomenon of recent di-
vergence of the clone from a common ancestor together
with ongoing transmission of the clone and ongoing evo-
lution of virulence genotype. Similarly, in the present
study the PFGE profiles of the ST131 isolates showed a
similarity level of 61% (Figure 2). All theses ST131 isolates
expressed the commonly described virulence genes in
ST131 clone including fimH, iha, sat, kpsM, fyuA and iutA,
however many of these isolates expressed uncommon
genes in this clone including papG allele II (5 isolates),











B2 non-ST131 B2 ST131 CTX-M-15 B2
ST131producers
N = 163 (%) N = 118 N = 45 N = 101 N = 52 N = 37 N = 24 N = 23
Total 910 730 180 671 463 332 193 186
Mean 5.58 6.18 4.0 6.64 8.90 8.97 8.04 8.08
Adhesin 3 (1.8) 2 (1.6) 1 (2.2) 2 (1.9) - 1 (2.7) - -
papG I
papG II 21 (12.8) 19 (16.1) * 2 (4.4) 19 (18.8)‡ 15 (28.8) † 10 (27.2) 5 (20.8) 5 (21.7)
papG III 36 (22.0) 30 (25.4) 6 (13.3) 30 (29.7) ‡ 25 (48.0) † 24 (64.8) γ 4 (16.6) 4 (17.3)
papC 35 (21.4) 29 (24.5) 6 (13.3) 29 (28.7) ‡ 25 (48.0) † 25 (67.5) γ 3 (12.5) 3 (13)
fimH 138 (84.7) 100 (84.7) 38 (84.4) 85 (84.2) 51 (98.1) † 36 (97.3) 24 (100) 23 (100)
afa/draBC 8 (4.9) 4 (3.3) 4 (8.8) 4 (3.9) 2 (3.8) 3 (8.1) 1 (4.1) 1 (4.3)
sfa/foc 26 (15.9) 20 (16.9) 6 (13.3) 20 (19.8) ‡ 18 (34.6) † 22 (59.4) γ - -
iha 49 (30.0) 45 (38.1) * 4 (8.8) 43 (42.5) ‡ 36 (69.2) † 14 (37.8) γ 24 (100) 23 (100)
hra 38 (23.3) 29 (24.5) 9 (20.0) 28 (27.7) 19 (36.5) † 24 (64.8) γ - -
Iron uptake 104 (63.8) 78 (66.1) 26 (57.7) 68 (67.3) 49 (94.2) † 33 (89.1) 24 (100) 23 (100)
fyuA
iutA 82 (50.3) 65 (55.0) * 17 (37.7) 60 (59.4) ‡ 37 (71.2) † 16 (43.2) γ 24 (100) 23 (100)
Toxin 27 (16.5) 24 (20.3) * 3 (6.6) 23 (22.8) ‡ 22 (42.3) † 24 (64.9) γ 2 (8.3) 2 (8.6)
hylA
cnfI 19 (11.6) 17 (14.4) 2 (4.4) 17 (16.8) ‡ 14 (26.9) † 15 (40.5) γ - -
sat 38 (23.3) 37 (31.3) * 1 (2.2) 35 (34.6) ‡ 30 (57.6) † 8 (21.6) γ 24 (100) 23 (100)
Cell protection 119 (73.0) 94 (79.6) * 25 (55.5) 84 (83.2) ‡ 40 (76.9) 28 (75.5) 18 (75) 18 (78.2)
traT
kpsM II 69 (42.3) 64 (54.2) * 5 (11.1) 59 (58.4) ‡ 45 (86.5) † 27 (72.9) γ 23 (95.8) 22 (95.6)
Other pheR 98 (60.1) 73 (61.8) 25 (55.5) 65 (64.3) 35 (67.3) 22 (59.4) 17 (70.8) 16 (69.5)
*: p < 0.05 for CTX-M producers vs. non CTX-M producers.
‡: p < 0.05 for CTX-M-15 producers vs. non CTX-M producers.
†: p < 0.05 for CTX-M-15 B2 producers vs. other phylogroup isolates with CTX-M-15.
γ: p < 0.05 for B2 non-ST131 isolates vs. B2 ST131 isolates.
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(1 isolate) and hylA (2 isolates) (Table 2). Clermont et al
have shown that the phylogroup B2 pandemic clone
ST131 is highly virulent in a mouse model, even though it
lacks several genes encoding key virulence factors (Pap,
Cnf1, HylA) [26]. Nevertheless, the recent findings of
Johnson et al point away from ST131 isolates as having
higher virulence potential compared with other E. coli
types in causing invasive infections in a murine sepsis
model [27]. Moreover, a recent study have demonstrated
that the ST131 clone has a genetic composition that
differs from other group B2 strains, and appears to be less
virulent than previously suspected [28]. In fact, in the
present study, the non-ST131-group B2 isolates, which
were significantly associated to CTX-M-15 ESBLs, had a
higher frequency of several genes encoding key virulence
factors such as adhesins hra, sfa/foc, papC and papG II
and the toxins hylA and cnf1 than had the ST131 isolates
(p < 0.01) (Table 3). Surprisingly, unlike most previously
published studies, where the ESBL-producing E. coli
isolates lacked the toxins hylA and cnf1, in our collectionthe group B2 isolates especially those carrying CTX-M
had a high frequency of hylA (42.6%) and cnfI (24.5%)
(Table 2) [22]. PFGE typing showed polyclonality with
sporadic cases and small clusters indicating that the rapid
increase of CTX-M-15 producing E. coli isolates could be
due to the incorporation of blaCTX-M-15 genes into group
B2 clones exhibiting high number of virulence factors as
well as ST131. Although ST131 was predominant in
2003-2004, it appeared to be replaced by group B2 strains
exhibiting a higher number of virulence factors in 2006
and 2009. The successful spread of CTX-M-15 was reported
to be also related to IncF plasmids. The blaCTX-M-15-carrying
plasmid studied here were also assigned to incompatibility
groups IncF in 72/88 plasmids and rarely to IncL/M, IncI1,
IncN and IncHI2. However, unlike other previous reports,
blaCTX-M-14 was carried often on non-typeable plasmids
(9/15) and not on Inc K or IncF replicons [5]. More than
half of the IncF plasmids carrying CTX-M-15 belonged to
the single FII replicon type (48/72). In fact the IncFII plas-
mids carrying blaCTX-M-15 are widely widespread; however,
IncF multireplicon plasmids, particularly FII-FIA-FIB, are
Table 4 Nature and number of addiction systems according to ESBL type and replicon type identified in the
recipient strains
Addiction modules, n
ESBL type n pemKIa ccdAB hok-sokb pndAC vagCDc Total Meand
All 144 84 29 51 5 18 187 1.29
TEM-26 2 2 0 0 0 0 2
SHV 39 12* 9 7* 0 3 31 0.79
SHV-2a 9 1 1
SHV-12 30 11 9 7 0 3 30 1.00
CTX-M 103 70 20 44 5 15 154 1.46
CTX-M-14 15 6 0 0 2 0 8 0.53
CTX-M-15 88 64 20 44 3 15 143 1.62
Replicon type n pemKIe ccdABf hok-sokg pndAC vagCDh Total Meani
A/C 5 0 0 0 0 0 0
N 4 0 0 0 0 0 0
L/M 14 9 0 0 0 0 9 0.64
IND 15 4 0 1 0 0 5 0.33
I1 5 2 0 0 5 2 9 1.80
HI2 16 0 0 0 0 2 2 0.12
F 85 69 29 50 0 14 162 1.90
SHV 12 10 9 6 0 1 26 2.16
CTX-M 73 59 20 44 0 13 136 1.87
FII 49 40 1 32 0 1 74 1.51
CTX-M-15 48 1
FII-FIB 4 2 1 2 0 0 5 1.25
SHV-2a 1 0 0 0 0 0
CTX-M-15 3 2 1 2 0 0
FII-FIA-FIB 18 15 14 11 0 9 49 2.72
SHV-12 3 3 2 3 0
CTX-M-15 15 12 12 9 9
FII-FIA 9 8 8 3 0 4 23 2.55
SHV-12 5 5 4 1 1
CTX-M-15 4 3 4 2 3
FIA-FIB 5 4 5 2 0 0 11 2.20
SHV-12 3 2 3 2
CTX-M15 2 2 2 0
a pemKI: CTX-M vs SHV, p < 0.001; CTX-M-15 vs other ESBLs, p < 0.001.
b hok-sok: CTX-M vs SHV, p < 0.01; CTX-M-15 vs other ESBLs, p < 0.001.
c vagCD: CTX-M vs SHV, p =0.23; CTX-M-15 vs other ESBLs, p = 0.03.
d Mean: CTX-M vs SHV, p <0.001; CTX-M-15 vs other ESBLs, p < 0.001.
e pemKI: IncF vs other plasmids, p < 0.001.
f ccdAB: IncF vs other plasmids, p < 0.001.
g hok-sok: IncF vs other plasmids, p < 0.001.
h vagCD: IncF vs other plasmids, p = 0.08, vagCD: IncF and IncI1 vs other plasmids, p = 0.01.
i Mean: IncF vs other plasmids, p < 0.001.
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which can promote stability in bacteria [2,5]. IncF plasmid
types are shown to be well-adapted to proliferate in E. coli,
but their successful retention in E. coli populations may
also be attributed to the presence of addictions systems. In
deed, here the frequency of addiction system was signifi-
cantly highest in IncF plasmids particularly multirepliconcomprising IncFIA. This is consistent with similar studies
conducted in France and recently in UK [7,8]. The pemKI,
hok-sok, and ccdAB were previously characterized in IncF
replicons; however the vagCD system which was reported
on Salmonella virulence plasmids was surprisingly abun-
dant in IncF CTX-M-15 carrying plasmids in the three
studies [9,29]. Of note, the vagCD system was significantly
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http://www.biomedcentral.com/1471-2180/13/147associated to CTX-M-15-plasmids carried on ST131 clone
in both the present study and the UK one (10/17 (58.8%)
and 26/39 (66%); respectively) [8]. In addition, another
recent study conducted in South Korea has shown that
vagCD system was more frequently found in CTX-M-
15-producing E. coli than in CTX-M-14-producing ones
and was surprisingly of high frequency in the main ST11
and ST15 CTX-M-producing-K. pneumoniae clones found
in South Africa [30]. Moreover, two recent other studies
have reported the presence of vagCD in IncA/C plasmids
carrying two successful carbapenemases NDM-1 and VIM-
1 in South Africa and in Canada, respectively [31,32]. Thus
this module, VagCD, appears to play a role in spread and
maintenance of many successful plasmids and resistant
clones worldwide. Finally, plasmid addiction systems
present exciting opportunities for the development of
novel antibacterial agents targeting pathogens harboring
multi-drug resistance plasmids. In fact, the exploitation of
addiction systems as an antibacterial strategy via artificial
activation of the toxin has been proposed and has consi-
derable potential; however efforts in this area remain in
early stages and many challenges are associated with artifi-
cial toxin activation [33].
Conclusion
In conclusion, the present study demonstrates the rapid
increase of CTX-M-producing E. coli isolates in Sfax-
Tunisia and the decline of SHV-type, mediated mainly
with the highly conjugative and adapted IncF plasmids
carrying blaCTX-M-15. This study furthermore illustrates
that the high prevalence of CTX-M-15 is not only due to
the spread of a single clone, mainly the pandemic ST131
clone, but is also associated to the spread of various IncF-
type plasmids harboring multiple addiction systems,
especially the vagCD system, into related clones with high
frequency of virulence determinants. The vagCD system,
which is associated to Salmonella virulence plasmids, was
significantly associated to the pandemic ST131 clone and
has been increasingly reported in various plasmids enco-
ding successful β-lactamases. Based on these findings,
larger multicenter studies to determine the contribution
of the addiction systems particularly vagCD in the main-
tenance and spread in of many successful multi-drug re-
sistance plasmids worldwide are warranted. Finally the
artificial activation of the VagC, the toxin of the VagCD
module, could be an exciting opportunity for the develop-
ment of novel antibacterial agents targeting many clones
bearing successful multi-drug resistance plasmids.
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